Cabrera LAE, Hernández HJM, Hernández GF, González GY, Noa AM, Fernández GM

Language: Spanish
References: 0
Page: 14-21
PDF size: 126.19 Kb.

ABSTRACT

Introduction: pancreatic cancer has the worst prognosis among malignant tumors with only 5% survival after five years of diagnosed patients. The diagnosis, usually late, is carried out when the disease is advanced or when there is metastasis.
Objective: to characterize the patients with histological diagnosis of stages III and IV pancreatic cancer, in which the tru-cut biopsy was applied as a technique for taking the sample.
Method: a descriptive study was carried out on 11 patients with stages III and IV pancreatic cancer whose histological confirmation was achieved by means of the tru-cut biopsy in the General Provincial Teaching Hospital of Ciego de Ávila in the period January-December 2017. The variables studied were: age, sex, topographic location, risk factors, histology, complications and survival.
Results: the age group of 66-81 years (45,45%), the male sex (63,64 %), the location in the head (54,55 %), and smoking (21,74 %) as a risk factor prevailed. Survival after seven months was high (90,90 %), and its highest range was 10-12 months. The complications were minimal and not serious.
Conclusions: patients diagnosed with pancreatic cancer stages III and IV were characterized according to the variables to be studied. In the course of the investigation, the survival achieved in them was shown given the onco-specific therapeutic possibilities fostered by the histological study, achieved by means of a tru-cut biopsy.